WO2009038089A1 - Agent anti-fatigue contenant de la sésamine et de la vitamine e - Google Patents

Agent anti-fatigue contenant de la sésamine et de la vitamine e Download PDF

Info

Publication number
WO2009038089A1
WO2009038089A1 PCT/JP2008/066766 JP2008066766W WO2009038089A1 WO 2009038089 A1 WO2009038089 A1 WO 2009038089A1 JP 2008066766 W JP2008066766 W JP 2008066766W WO 2009038089 A1 WO2009038089 A1 WO 2009038089A1
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
sesamin
fatigue agent
fatigue
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2008/066766
Other languages
English (en)
Japanese (ja)
Inventor
Daisuke Takemoto
Yoshiko Ono
Yoko Yasutake
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suntory Holdings Ltd
Suntory Ltd
Original Assignee
Suntory Holdings Ltd
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd, Suntory Ltd filed Critical Suntory Holdings Ltd
Priority to JP2009533157A priority Critical patent/JP5794761B2/ja
Publication of WO2009038089A1 publication Critical patent/WO2009038089A1/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C07D311/72—3,4-Dihydro derivatives having in position 2 at least one methyl radical and in position 6 one oxygen atom, e.g. tocopherols
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

La présente invention concerne une composition de haute innocuité pour le corps humain ou un animal, qui peut être ingérée en continu. La composition contient de la sésamine et de la vitamine E et produit un effet anti-fatigue.
PCT/JP2008/066766 2007-09-19 2008-09-17 Agent anti-fatigue contenant de la sésamine et de la vitamine e Ceased WO2009038089A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2009533157A JP5794761B2 (ja) 2007-09-19 2008-09-17 セサミン類及びビタミンｅを含有する抗疲労剤

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007243136 2007-09-19
JP2007-243136 2007-09-19

Publications (1)

Publication Number Publication Date
WO2009038089A1 true WO2009038089A1 (fr) 2009-03-26

Family

ID=40467899

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/066766 Ceased WO2009038089A1 (fr) 2007-09-19 2008-09-17 Agent anti-fatigue contenant de la sésamine et de la vitamine e

Country Status (2)

Country Link
JP (1) JP5794761B2 (fr)
WO (1) WO2009038089A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021065664A1 (fr) * 2019-10-04 2021-04-08
CN114502157A (zh) * 2019-10-04 2022-05-13 三得利控股株式会社 抑制肌肉量的降低、预防其降低、维持、恢复或增加肌肉量用组合物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04368326A (ja) * 1991-06-15 1992-12-21 Suntory Ltd 新規組成物
WO2004105749A1 (fr) * 2003-05-27 2004-12-09 Suntory Limited Composition presentant une activite de modulation du nerf du systeme autonome et procede d'utilisation associe
WO2007119378A1 (fr) * 2006-03-15 2007-10-25 Suntory Limited Composition contenant de la riboflavine et des sésamines

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04368326A (ja) * 1991-06-15 1992-12-21 Suntory Ltd 新規組成物
WO2004105749A1 (fr) * 2003-05-27 2004-12-09 Suntory Limited Composition presentant une activite de modulation du nerf du systeme autonome et procede d'utilisation associe
WO2007119378A1 (fr) * 2006-03-15 2007-10-25 Suntory Limited Composition contenant de la riboflavine et des sésamines

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DEVI, S. A. ET AL.: "Dietary vitamin E and physical exercise: I. Altered endurance capacity and plasma lipid profile in ageing rats", EXPERIMENTAL GERONTOLOGY, vol. 38, no. 3, 2003, pages 285 - 290 *
KEIICHI HIRAMOTO ET AL.: "Sanka Stress to Hiro", IGAKU NO AYUMI, vol. 204, no. 5, 2003, pages 309 - 313 *
MASAMI HARADA: "Sesamin no Seirikassei -Kosanka Sayo to Seitai Bogyo", BIO INDUSTRY, vol. 17, no. 3, 2000, pages 23 - 31 *
NOVELLI, G. P. ET AL.: "Spin-trappers and vitamin E prolong endurance to muscle fatigue in mice", FREE RADICAL BIOLOGY & MEDICINE, vol. 8, no. 1, 1990, pages 9 - 13 *
YOSUKE KATAOKA: "Sanka Stress to No no Hiro", IGAKU NO AYUMI, vol. 204, no. 5, 2003, pages 314 - 318 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2021065664A1 (fr) * 2019-10-04 2021-04-08
CN114502157A (zh) * 2019-10-04 2022-05-13 三得利控股株式会社 抑制肌肉量的降低、预防其降低、维持、恢复或增加肌肉量用组合物
CN114514022A (zh) * 2019-10-04 2022-05-17 三得利控股株式会社 维持生活活动量、预防其降低、抑制或改善其降低用组合物
EP4039329A4 (fr) * 2019-10-04 2023-08-02 Suntory Holdings Limited Composition de suppression de la baisse de masse musculaire, prévention de la baisse à l'intérieur, son entretien, sa récupération ou son augmentation à l'intérieur
JP2024098986A (ja) * 2019-10-04 2024-07-24 サントリーホールディングス株式会社 生活活動量の維持、低下予防、低下抑制又は改善用組成物
TWI888414B (zh) * 2019-10-04 2025-07-01 日商三得利控股股份有限公司 生活活動量之維持、預防降低、抑制降低或改善用組成物之使用

Also Published As

Publication number Publication date
JPWO2009038089A1 (ja) 2011-01-06
JP5794761B2 (ja) 2015-10-14

Similar Documents

Publication Publication Date Title
EP1991218A4 (fr) Utilisation de cyclolignans dans le traitement du diabète de type 2 et comme contraceptifs
PL2086642T3 (pl) DNaza do leczenia męskiej subpłodności
IL198289A (en) Processed dihydropyrazolones, processes for their preparation, medicinal preparations containing them and their use in the preparation of medicinal preparations
EP2076198A4 (fr) Induction d'effets souhaitables de température sur un tissu humain
WO2007100535A3 (fr) Dérivés d'oxyntomoduline
GB2443287B (en) Methods, compositions and formulations for the treatment of thyroid eye disease
EP2006284A4 (fr) Dérivés de dicyclooctane, procédés d'élaboration et utilisations médicales
CA121105S (en) Helicopter
IL197877A (en) Uses of aminomethyl-4-imidazole derivatives for the preparation of medications and medications containing them
WO2008034013A3 (fr) Dispositifs médicaux et procédés de réalisation desdits dispositifs
IL207038A (en) History of Diazaspiro [5.5] Undecan, Pharmaceuticals Containing them, and their use in the preparation of drugs for the treatment or reduction of the risk of disease or inflammatory condition
WO2008053444A3 (fr) Méthodes visant à traiter un trouble respiratoire au moyen d'un traitement probiotique
MY147247A (en) Organic compounds and their uses
PL2057153T3 (pl) POCHODNE (3-ARYLO-PIPERAZYN-1-YLOWE) 6,7-DIALKOKSYCHINAZOLINY, 6,7-DIALKOKSYFTALAZYNY i 6,7-DIALKOKSYIZOCHINOLINY
IL198112A0 (en) 3-aminoimidazo [1,2-a]pyridine derivatives having an sglt1-and sglt2-inhibiting action for the treatment of type 1 and type 2 diabetes
WO2009040445A3 (fr) Arabinoxylo-oligosaccharides utiles contre des infections gastro-intestinales
CA121119S (en) Helicopter
GB2452366B (en) An aid for the prevention of sudden infant death syndrome
GB0612096D0 (en) Functional imaging of the retina
WO2008046865A3 (fr) Système d'alimentation à long terme pour personnes agées
ZA201003794B (en) Novel 1,3-dihydro-5-isobenzofurancarbonitrile derivatives and pharmaceutical composition thereof for the treatment of premature ejaculation
IL194880A (en) Aminazole amine derivatives, their use in the treatment of diseases and pharmaceuticals containing them
IL202523A0 (en) Buspirone for the treatment of mausea and vomiting
WO2008093247A3 (fr) Médicament pour le traitement de l'endométriose
PT1938684E (pt) Utilização de polioximetilenodialquiléteres e/ou de acetais de dialdeído para a preservação de corpos humanos ou animais, e composições contendo-os

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08831590

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2009533157

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08831590

Country of ref document: EP

Kind code of ref document: A1